Cardiology
Jacc Intervention Publishes Mivs Vestasync I Trial Preliminary Results
Published in Hospital Law Weekly, November 6th, 2008
MIV Therapeutics, Inc. (OTC/BB: MIVI) (Frankfurt: MIV), a leading developer of next-generation coatings and advanced drug-delivery systems for cardiovascular stents and other implantable medical devices, announced that the Journal of the American College of Cardiology Intervention (JACC Intervention) published preliminary results from the VESTASYNC I trial. The peer-reviewed article entitled "Preliminary Results of the Hydroxyapatite Non-Polymer-Based Sirolimus-Eluting Stent for the Treatment of Single De Novo Coronary Lesions - A First-In-Human Analysis of a Third Generation Drug-Eluting Stent (DES) System" appears in the October 21st edition of JACC and is available online at...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2008-11-06)
More Articles from Hospital Law Weekly
- Breast Cancer
Metropolitan Chicago Breast Cancer Task Force Reports on Progress Toward Reducing the Black-White Disparity in Breast Cancer Mortality and Improving Breast Health for All Women - Cancer Vaccines
Doctor Recommends New Powerful Natural Antiviral Against the Flu - Clinical Microbiology
Study results from J.P. Marcel and colleagues broaden understanding of clinical microbiology - Clinical Orthopedics
New clinical orthopedics research from W. Alkharusi et al outlined - Commonwealth Fund
Extra payments to private FFS Medicare advantage plans to total $2.5B in 2008 - Eric Drew
Credit Card Companies Accomplices in Millions of Identity Theft Cases Alleges Eric Drew - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
